Physiological Effect: Increased Glutathione Concentration
✉ Email this page to a colleague
Drugs with Physiological Effect: Increased Glutathione Concentration
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eugia Pharma | ACETYLCYSTEINE | acetylcysteine | INJECTABLE;INTRAVENOUS | 207358-001 | Feb 29, 2016 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Hospira | ACETYLCYSTEINE | acetylcysteine | SOLUTION;INHALATION, ORAL | 073664-001 | Aug 30, 1994 | AN | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Alvogen | ACETYLCYSTEINE | acetylcysteine | SOLUTION;INHALATION, ORAL | 203853-001 | Jun 21, 2012 | AN | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Hospira | ACETYLCYSTEINE | acetylcysteine | SOLUTION;INHALATION, ORAL | 074037-001 | Aug 30, 1994 | AN | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Glenmark Pharms Inc | ACETYLCYSTEINE | acetylcysteine | INJECTABLE;INTRAVENOUS | 213693-001 | Feb 3, 2022 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Alvogen | ACETYLCYSTEINE | acetylcysteine | SOLUTION;INHALATION, ORAL | 204674-001 | Feb 11, 2014 | AN | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
